DEBORAH MARTIN: Open Payments
NPI 1518166636 · WATERVILLE, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 10 payments from 7 companies in 2025. Trend: 2023 $526 · 2024 $569 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Ardelyx, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
Products named: ZENPEP, ENTYVIO, XIFAXAN, VOQUEZNA, IBSRELA, RINVOQ, OMVOH, SKYRIZI.
Industry payments across ME — which companies pay providers there.
